ZA944238B - New use of old drugs - Google Patents

New use of old drugs

Info

Publication number
ZA944238B
ZA944238B ZA944238A ZA944238A ZA944238B ZA 944238 B ZA944238 B ZA 944238B ZA 944238 A ZA944238 A ZA 944238A ZA 944238 A ZA944238 A ZA 944238A ZA 944238 B ZA944238 B ZA 944238B
Authority
ZA
South Africa
Prior art keywords
new use
old drugs
drugs
old
new
Prior art date
Application number
ZA944238A
Other languages
English (en)
Inventor
Guido Peter Kroemer
Jose Angel Gonzalo
Carlos Martinez Alonso
Terje Kalland
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of ZA944238B publication Critical patent/ZA944238B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA944238A 1993-07-26 1994-06-15 New use of old drugs ZA944238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302490A SE9302490D0 (sv) 1993-07-26 1993-07-26 New use of old drugs

Publications (1)

Publication Number Publication Date
ZA944238B true ZA944238B (en) 1995-02-16

Family

ID=20390672

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944238A ZA944238B (en) 1993-07-26 1994-06-15 New use of old drugs

Country Status (9)

Country Link
US (1) US5776947A (fr)
EP (1) EP0711165A1 (fr)
JP (1) JPH09500640A (fr)
AU (1) AU7278294A (fr)
EE (1) EE03150B1 (fr)
IL (1) IL110201A (fr)
SE (1) SE9302490D0 (fr)
WO (1) WO1995003051A1 (fr)
ZA (1) ZA944238B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0486526T3 (da) 1989-08-07 1996-06-24 Peptide Technology Ltd Bindingsligander for tumornekrosefaktor
US5959087A (en) * 1989-08-07 1999-09-28 Peptide Technology, Ltd. Tumour necrosis factor binding ligands
US20030225254A1 (en) * 1989-08-07 2003-12-04 Rathjen Deborah Ann Tumour necrosis factor binding ligands
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
US7192584B2 (en) * 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US20050260201A1 (en) * 1993-01-29 2005-11-24 Centocor, Inc. Methods of treating rheumatoid arthritis using anti-TNF receptor fusion proteins
PL329922A1 (en) * 1996-05-20 1999-04-26 Darwin Discovery Ltd Quinoline carboxamides as inhibitors of the tumour necrosis factor and of phosphodiesterase
WO1997044322A1 (fr) * 1996-05-20 1997-11-27 Darwin Discovery Limited Sulfonamides de quinoline en tant qu'inhibiteurs de tnf et inhibiteurs de photodiesterase-iv
WO2000051637A1 (fr) * 1999-03-02 2000-09-08 Centocor, Inc. ANTICORPS ANTI-TNF$G(a) UTILISES DANS LA THERAPIE DE L'ASTHME
US20050249735A1 (en) * 2000-08-07 2005-11-10 Centocor, Inc. Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor
US20110195063A1 (en) * 2000-08-07 2011-08-11 Centocor, Inc. Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor
US20060018907A1 (en) * 2000-08-07 2006-01-26 Centocor, Inc. Anti-TNF antibodies and peptides of human tumor necrosis factor
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US20090038182A1 (en) * 2007-08-09 2009-02-12 Lans Maris J Footwear with built-in scale
US10465003B2 (en) 2016-02-05 2019-11-05 Janssen Biotech, Inc. Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
SE469368B (sv) * 1991-10-09 1993-06-28 Kabi Pharmacia Ab Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Also Published As

Publication number Publication date
EE03150B1 (et) 1999-02-15
AU7278294A (en) 1995-02-20
SE9302490D0 (sv) 1993-07-26
JPH09500640A (ja) 1997-01-21
WO1995003051A1 (fr) 1995-02-02
IL110201A0 (en) 1994-10-21
US5776947A (en) 1998-07-07
IL110201A (en) 1999-06-20
EP0711165A1 (fr) 1996-05-15

Similar Documents

Publication Publication Date Title
PL304317A1 (en) Pharmaceutical agent
PL304508A1 (en) Pharmaceutical agent
GB2255503B (en) Improved use of ß2-bronchodilator drugs
GB9526560D0 (en) Use of 2-Amino-Heterocycles
ZA944238B (en) New use of old drugs
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
ZA96725B (en) Use of phenyclyclohexylcarboxamides
GB9317752D0 (en) New pharmaceutical use
ZA932553B (en) New use of B-carbolines
SG48900A1 (en) Use of ferrocene
GB9311423D0 (en) New use
GB9304745D0 (en) Use of pharmaceutical formulations
GB9523066D0 (en) Compounds and their therapeutic use
PL297548A1 (en) Pharmaceutical agent
GB9323132D0 (en) New pharmaceutical use
GB9322915D0 (en) New pharmaceutical use
GB9305079D0 (en) New pharmaceutical use
GB9204587D0 (en) New pharmaceutical use
GB9204390D0 (en) New pharmaceutical use
GB9312343D0 (en) Pharmaceutical use
GB9324252D0 (en) Pharmaceutical use
GB9522632D0 (en) New pharmaceutical use
GB9505678D0 (en) New pharmaceutical use
GB9503709D0 (en) New pharmaceutical use